Admission Date:  [**2147-2-9**]       Discharge Date:  [**2147-2-19**]  Date of Birth:   [**2075-3-29**]       Sex:  M  Service:  HISTORY OF PRESENT ILLNESS:  The patient is a 71 year old male with a history of hypertension, hypercholesterolemia, past tobacco use, past myocardial infarction in [**2133**] and left circumflex percutaneous transluminal coronary angioplasty in [**2133**].
The patient was started on heparin and given one dose of Coumadin last night.
The patient was transferred to [**Hospital1 188**] for cardiac catheterization to rule out ischemia and further evaluation for surgical intervention.
Coronary artery disease status post non Q wave myocardial infarction in [**2133**] and status post left circ percutaneous transluminal coronary angioplasty in [**2133**].
Atenolol 100 mg p.o.
Accupril 10 mg p.o.
Folic acid 1 mg p.o.
Tagamet 800 mg p.o.
At the outside hospital he was on Lipitor 20 mg p.o.
q.d., aspirin 81 mg p.o.
q.d., Pepcid 40 mg p.o.
q.d., heparin 1100 units/hr and Coumadin 5 mg p.o.
On [**2147-2-13**], the patient underwent a mitral valve repair with a 29 mm [**First Name8 (NamePattern2) 1495**] [**Male First Name (un) 923**] valve.
He was weaned off of his Neo drip on postoperative day number one and his chest tube was removed on postoperative day number one.
The patient was started on heparin with the start of his stroke symptoms.
The patient was also started on Coumadin.
Occupational Therapy also saw the patient on [**2147-2-17**] and thought that he would be appropriate for short term rehabilitation.
On postoperative day number six, [**2147-2-19**], the patient was ready for rehabilitation and was transferred to the rehabilitation facility.
The patient's medications on discharge were 1.
Coumadin 7.5 mg p.o.
Heparin drip 1000 units/hr until therapeutic on the Coumadin and then off.
Lipitor 20 mg p.o.
Calcium carbonate 500 mg p.o.
Lopressor 25 mg p.o.
Captopril 12.5 mg p.o.
Percocet 325 one to two tabs one p.o.
Lasix 20 mg p.o.
KCL 20 mg p.o.
Colace 100 mg p.o.
Aspirin 325 mg p.o.
Oxazepam 15-30 mg p.o.
